Skip to main content
Equibles

BAFNAPH · Bafna Pharmaceuticals Limited · Financials

Use BAFNAPH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BAFNAPH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
482.05 INR -9.80 (-1.99%) At close · Nov 13
Rebalance outlook locked
Market Cap
11.40B INR
Shares
23.66M
Volume · Nov 13 55.49K Avg daily vol (3M) 7609

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
1.51B +3.3%
FY2026 Revenue FY2020–FY2026
Net Income
111M +167.3%
FY2026 Net Income FY2020–FY2026
Operating Cash Flow
153.71M -30.6%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
INR 1.55B 1.51B 1.46B 1.52B 1.15B 851.4M 712.18M 424.72M
INR 68.79M 60.73M 48.9M 49.95M 53.34M 54.93M 44.78M 32.67M
INR 38.48M 36.61M 27.31M 22.9M 20.38M 7.94M 7.42M 955K
INR 113.8M 109.7M 41.53M 73.48M 116.16M 51.51M 58.27M -252.04M
INR -1.3M -1.3M 0 0 2.78M 0 0 0
INR 115.09M 111M 41.53M 73.48M 113.38M 51.51M 58.27M -252.04M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.